<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33505216</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.</ArticleTitle><Pagination><StartPage>6699560</StartPage><MedlinePgn>6699560</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6699560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/6699560</ELocationID><Abstract><AbstractText>Licorice extract is a Chinese herbal medication most often used as a demulcent or elixir. The extract usually consists of many components but the key ingredients are glycyrrhizic (GL) and glycyrrhetinic acid (GA). GL and GA function as potent antioxidants, anti-inflammatory, antiviral, antitumor agents, and immuneregulators. GL and GA have potent activities against hepatitis A, B, and C viruses, human immunodeficiency virus type 1, vesicular stomatitis virus, herpes simplex virus, influenza A, severe acute respiratory syndrome-related coronavirus, respiratory syncytial virus, vaccinia virus, and arboviruses. Also, GA was observed to be of therapeutic valve in human enterovirus 71, which was recognized as the utmost regular virus responsible for hand, foot, and mouth disease. The anti-inflammatory mechanism of GL and GA is realized via cytokines like interferon-<i>&#x3b3;</i>, tumor necrotizing factor-<i>&#x3b1;</i>, interleukin- (IL-) 1<i>&#x3b2;</i>, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, and IL-17. They also modulate anti-inflammatory mechanisms like intercellular cell adhesion molecule 1 and P-selectin, enzymes like inducible nitric oxide synthase (iNOS), and transcription factors such as nuclear factor-kappa B, signal transducer and activator of transcription- (STAT-) 3, and STAT-6. Furthermore, DCs treated with GL were capable of influencing T-cell differentiation toward Th1 subset. Moreover, GA is capable of blocking prostaglandin-E2 synthesis via blockade of cyclooxygenase- (COX-) 2 resulting in concurrent augmentation nitric oxide production through the enhancement of iNOS2 mRNA secretion in Leishmania-infected macrophages. GA is capable of inhibiting toll-like receptors as well as high-mobility group box 1.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Seidu A. Richard.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Seidu A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-3475-0363</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Princefield University, P. O. Box MA 128, Ho, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011453">Prostaglandins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>6FO62043WK</RegistryNumber><NameOfSubstance UI="D019695">Glycyrrhizic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="C496319">NOS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D011451">Prostaglandin-Endoperoxide Synthases</NameOfSubstance></Chemical><Chemical><RegistryNumber>P540XA09DR</RegistryNumber><NameOfSubstance UI="D006034">Glycyrrhetinic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006034" MajorTopicYN="N">Glycyrrhetinic Acid</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006035" MajorTopicYN="N">Glycyrrhiza</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019695" MajorTopicYN="N">Glycyrrhizic Acid</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007891" MajorTopicYN="N">Leishmania</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011451" MajorTopicYN="N">Prostaglandin-Endoperoxide Synthases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011453" MajorTopicYN="N">Prostaglandins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33505216</ArticleId><ArticleId IdType="pmc">PMC7808814</ArticleId><ArticleId IdType="doi">10.1155/2021/6699560</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe N., Ebina T., Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiology and Immunology. 1982;26(6):535&#x2013;539. doi: 10.1111/j.1348-0421.1982.tb00207.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1982.tb00207.x</ArticleId><ArticleId IdType="pubmed">6290851</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer D., Czarczynska-Goslinska B., Goslinski T. Glycyrrhetinic acid and its derivatives in infectious diseases. Current Issues in Pharmacy and Medical Sciences. 2016;29(3):118&#x2013;123. doi: 10.1515/cipms-2016-0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cipms-2016-0024</ArticleId></ArticleIdList></Reference><Reference><Citation>Maione F., Minosi P., di Giannuario A., et al. Long-lasting anti-inflammatory and antinociceptive effects of acute ammonium glycyrrhizinate administration: pharmacological, biochemical, and docking studies. Molecules. 2019;24(13):p. 2453. doi: 10.3390/molecules24132453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24132453</ArticleId><ArticleId IdType="pmc">PMC6651237</ArticleId><ArticleId IdType="pubmed">31277398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordbar N., Karimi M. H., Amirghofran Z. The effect of glycyrrhizin on maturation and T cell stimulating activity of dendritic cells. Cellular Immunology. 2012;280(1):44&#x2013;49. doi: 10.1016/j.cellimm.2012.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2012.11.013</ArticleId><ArticleId IdType="pubmed">23261828</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamsa F., Ohtsuki K., Hasanzadeh E., Rezazadeh S. The anti-inflammatory and anti-viral effects of an ethnic medicine: glycyrrhizin. Journal of Medicinal Plants. 2010;9(33):1&#x2013;28.</Citation></Reference><Reference><Citation>Wang Y. M., Du G. Q. Glycyrrhizic acid prevents enteritis through reduction of NF-&#x3ba;B p65 and p38MAPK expression in rat. Molecular Medicine Reports. 2016;13(4):3639&#x2013;3646. doi: 10.3892/mmr.2016.4981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4981</ArticleId><ArticleId IdType="pubmed">26955884</ArticleId></ArticleIdList></Reference><Reference><Citation>Crance J.-M., L&#xe9;v&#xea;que F., Biziagos E., van Cuyck-Gandr&#xe9; H., Jouan A., Deloince R. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Antiviral Research. 1994;23(1):63&#x2013;76. doi: 10.1016/0166-3542(94)90033-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(94)90033-7</ArticleId><ArticleId IdType="pubmed">8141593</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J. H., Iwatani Y., Ishida T., et al. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology. 2001;103(2):235&#x2013;243. doi: 10.1046/j.1365-2567.2001.01224.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.2001.01224.x</ArticleId><ArticleId IdType="pmc">PMC1783229</ArticleId><ArticleId IdType="pubmed">11412311</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Isobe K., Nagase F., et al. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. Immunology. 1993;79(4):p. 528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421919</ArticleId><ArticleId IdType="pubmed">8406577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Yang L., Howard O., Oppenheim J. J. Dendritic cells as a pharmacological target of traditional Chinese medicine. Cellular &amp; Molecular Immunology. 2006;3(6):401&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257493</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T. The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice. European Journal of Pharmacology. 2000;387(2):229&#x2013;232. doi: 10.1016/s0014-2999(99)00807-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-2999(99)00807-9</ArticleId><ArticleId IdType="pubmed">10650164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ploeger B., Mensinga T., Sips A., Seinen W., Meulenbelt J., DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metabolism Reviews. 2001;33(2):125&#x2013;147. doi: 10.1081/dmr-100104400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/dmr-100104400</ArticleId><ArticleId IdType="pubmed">11495500</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenwick G., Lutomski J., Nieman C. Liquorice, Glycyrrhiza glabra L. --Composition, uses and analysis. Food Chemistry. 1990;38(2):119&#x2013;143. doi: 10.1016/0308-8146(90)90159-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0308-8146(90)90159-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming L. J., Yin A. C. Y. Therapeutic effects of glycyrrhizic acid. Natural Product Communications. 2013;8(3, article 1934578X1300800335) doi: 10.1177/1934578x1300800335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578x1300800335</ArticleId><ArticleId IdType="pubmed">23678825</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossum T. V., Vulto, Man R. A. D., Brouwer, Schalm Glycyrrhizin as a potential treatment for chronic hepatitis C. Alimentary Pharmacology &amp; Therapeutics. 1998;12(3):199&#x2013;205. doi: 10.1046/j.1365-2036.1998.00309.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.1998.00309.x</ArticleId><ArticleId IdType="pubmed">9570253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq U. A., Masoud M. S., Nawaz Z., Riazuddin S. Glycyrrhizin as antiviral agent against hepatitis C virus. Journal of Translational Medicine. 2011;9(1, article 800):1&#x2013;7. doi: 10.1186/1479-5876-9-112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-9-112</ArticleId><ArticleId IdType="pmc">PMC3169469</ArticleId><ArticleId IdType="pubmed">21762538</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L., Kondratenko R., Baltina L. A., Jr., Plyasunova O. A., Pokrovskii A. G., Tolstikov G. A. Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review) Pharmaceutical Chemistry Journal. 2009;43(10, article 348):539&#x2013;548. doi: 10.1007/s11094-010-0348-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11094-010-0348-2</ArticleId><ArticleId IdType="pmc">PMC7089237</ArticleId><ArticleId IdType="pubmed">32214533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore C., Eisenhut M., Krausse R., et al. Antiviral effects ofGlycyrrhiza species. Phytotherapy Research. 2008;22(2):141&#x2013;148. doi: 10.1002/ptr.2295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2295</ArticleId><ArticleId IdType="pmc">PMC7167979</ArticleId><ArticleId IdType="pubmed">17886224</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada S., Maekawa T., Haneda E., Morikawa Y., Nagata N., Ohtsuki K. Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetinic acid derivative. Biological and Pharmaceutical Bulletin. 1998;21(12):1282&#x2013;1285. doi: 10.1248/bpb.21.1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.21.1282</ArticleId><ArticleId IdType="pubmed">9881639</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Yang R., Yuan B., Liu Y., Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharmaceutica Sinica B. 2011;5(4):310&#x2013;315. doi: 10.1016/j.apsb.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2015.05.005</ArticleId><ArticleId IdType="pmc">PMC4629407</ArticleId><ArticleId IdType="pubmed">26579460</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M. H., Eshraghi S., Noroozi M. Antibacterial effect of glycyrrhetinic acid on 55 hospital strains of staphylococcus aureus and 32 actinobacillus actinomycetemcomitans. DARU Journal of Pharmaceutical Sciences. 2001;9(3-4):37&#x2013;39.</Citation></Reference><Reference><Citation>Nitalikar M. M., Munde K. C., Dhore B. V., Shikalgar S. N. Studies of antibacterial activities of Glycyrrhiza glabra root extract. International Journal of PharmTech Research. 2010;2(1):899&#x2013;901.</Citation></Reference><Reference><Citation>Salari M., Kadkhoda Z. In vitro antibacterial effects of glycyrrhetinic acid on periodontopathogenic and capnophilic bacteria isolated from adult periodontitis. Clinical Microbiology and Infection. 2003;9(9):987&#x2013;988. doi: 10.1046/j.1469-0691.2003.00721.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-0691.2003.00721.x</ArticleId><ArticleId IdType="pubmed">14616694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues I. A., Mazotto A. M., Cardoso V., et al. Natural products: insights into leishmaniasis inflammatory response. Mediators of Inflammation. 2015;2015:12. doi: 10.1155/2015/835910.835910</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/835910</ArticleId><ArticleId IdType="pmc">PMC4619978</ArticleId><ArticleId IdType="pubmed">26538837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Bhattacharjee A., Majumder S., Majumdar S. B., Majumdar S. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. Journal of Antimicrobial Chemotherapy. 2012;67(8):1905&#x2013;1914. doi: 10.1093/jac/dks159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks159</ArticleId><ArticleId IdType="pubmed">22589456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;henb&#xfc;hl S., Hasler F., Frey B. M., Frey F. J., Brenneisen R., Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. The Journal of Clinical Endocrinology &amp; Metabolism. 1994;78(3):581&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">8126129</ArticleId></ArticleIdList></Reference><Reference><Citation>Akao T. Localization of enzymes involved in metabolism of glycyrrhizin in contents of rat gastrointestinal tract. Biological and Pharmaceutical Bulletin. 1997;20(2):122&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">9057971</ArticleId></ArticleIdList></Reference><Reference><Citation>Akao T., Akao T., Kobashi K. Glycyrrhizin &#x3b2;-D-glucuronidase of Eubacterium sp. from human intestinal flora. Chemical and Pharmaceutical Bulletin. 1987;35(2):705&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">3594680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori M., Sakamoto T., Kobashi K., Namba T. Metabolism of glycyrrhizin by human intestinal flora. Planta Medica. 1983;48(5):38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">6611743</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelis M., Geiler J., Naczk P., et al. Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Medical Microbiology and Immunology. 2010;199(4):291&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087222</ArticleId><ArticleId IdType="pubmed">20386921</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rossum T. G., Vulto A. G., Hop W. C., Schalm S. W. Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clinical Therapeutics. 1999;21(12):2080&#x2013;2090.</Citation><ArticleIdList><ArticleId IdType="pubmed">10645755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida S., Sakiya Y., Ichikawa T., AwAzu S. Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats. Chemical and Pharmaceutical Bulletin. 1989;37(9):2509&#x2013;2513.</Citation><ArticleIdList><ArticleId IdType="pubmed">2605701</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf8;rmer F., Reistad R., Alexander J. Glycyrrhizic acid in liquorice&#x2014;evaluation of health hazard. Food and Chemical Toxicology. 1993;31(4):303&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">8386690</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker B. R., Edwards C. R. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinology and Metabolism Clinics of North America. 1994;23(2):359&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">8070427</ArticleId></ArticleIdList></Reference><Reference><Citation>Feehan K. T., Gilroy D. W. Is resolution the end of inflammation? Trends in Molecular Medicine. 2019;25(3):198&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">30795972</ArticleId></ArticleIdList></Reference><Reference><Citation>Manns M. P., Wedemeyer H., Singer A., et al. Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. Journal of Viral Hepatitis. 2012;19(8):537&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3584517</ArticleId><ArticleId IdType="pubmed">22762137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsuki K., Abe Y., Shimoyama Y., Furuya T., Munakata H., Takasaki C. Separation of phospholipase A2 in Habu snake venom by glycyrrhizin (GL)-affinity column chromatography and identification of a GL-sensitive enzyme. Biological and Pharmaceutical Bulletin. 1998;21(6):574&#x2013;578. doi: 10.1248/bpb.21.574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.21.574</ArticleId><ArticleId IdType="pubmed">9657040</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimoyama Y., Ohtaka H., Nagata N., Munakata H., Hayashi N., Ohtsuki K. Physiological correlation between glycyrrhizin, glycyrrhizin-binding lipoxygenase and casein kinase II. FEBS Letters. 1996;391(3):238&#x2013;242. doi: 10.1016/0014-5793(96)00744-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(96)00744-2</ArticleId><ArticleId IdType="pubmed">8764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui S., Matsumoto H., Sonoda Y., et al. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. International Immunopharmacology. 2004;4(13):1633&#x2013;1644. doi: 10.1016/j.intimp.2004.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2004.07.023</ArticleId><ArticleId IdType="pmc">PMC7106177</ArticleId><ArticleId IdType="pubmed">15454116</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo X., Sun X., Cao Z., et al. Optimal ratio of 18&#x3b1;-and 18&#x3b2;-glycyrrhizic acid for preventing alcoholic hepatitis in rats. Experimental and Therapeutic Medicine. 2019;18(1):172&#x2013;178. doi: 10.3892/etm.2019.7572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7572</ArticleId><ArticleId IdType="pmc">PMC6566121</ArticleId><ArticleId IdType="pubmed">31258651</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Yuan B.-C., Ma Y.-S., Zhou S., Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharmaceutical Biology. 2017;55(1):5&#x2013;18. doi: 10.1080/13880209.2016.1225775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2016.1225775</ArticleId><ArticleId IdType="pmc">PMC7012004</ArticleId><ArticleId IdType="pubmed">27650551</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C., Li X., Wu J., et al. Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2/arachidonic acid pathway. Inflammation. 2015;38(4):1639&#x2013;1648. doi: 10.1007/s10753-015-0140-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-015-0140-2</ArticleId><ArticleId IdType="pubmed">25691139</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z., Zhang W., Ma L., Qiu Z. Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung injury induced by paraquat poisoning. European Review for Medical and Pharmacological Sciences. 2014;18(3):311&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">24563429</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Qin J., Lu S. Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injury. International Journal of Clinical and Experimental Pathology. 2014;7(8):p. 4755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152036</ArticleId><ArticleId IdType="pubmed">25197346</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J. Y., Cao H. Y., Liu P., Cheng G. H., Sun M. Y. Glycyrrhizic acid in the treatment of liver diseases: literature review. BioMed Research International. 2014;2014:15.872139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052927</ArticleId><ArticleId IdType="pubmed">24963489</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;felbauer B., Raffetseder J., Hauner M., Wolkerstorfer A., Ernst W., Szolar O. H. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochemical Journal. 2009;421(3):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">19442240</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda H., Nagai Y., Matsunaga T., et al. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. Journal of Leukocyte Biology. 2012;91(6):967&#x2013;976. doi: 10.1189/jlb.0112038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0112038</ArticleId><ArticleId IdType="pubmed">22422925</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman R. M., Gutchinov B., Witmer M. D., Nussenzweig M. C. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. The Journal of Experimental Medicine. 1983;157(2):613&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2186925</ArticleId><ArticleId IdType="pubmed">6185614</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Nussenzweig M. C. Development and homeostasis of dendritic cells. European Journal of Immunology. 2010;40(8):2099&#x2013;2102.</Citation><ArticleIdList><ArticleId IdType="pubmed">20853493</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin M., Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5904714</ArticleId><ArticleId IdType="pubmed">29313948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisch R. Immunogenic versus tolerogenic dendritic cells: a matter of maturation. International Reviews of Immunology. 2010;29(2):111&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">20367138</ArticleId></ArticleIdList></Reference><Reference><Citation>Miloud T., H&#xe4;mmerling G. J., Garbi N. Dendritic Cell Protocols. Springer; 2010. Review of murine dendritic cells: types, location, and development; pp. 21&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941103</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadmehr A., Pourfathollah A. A., Amirghofran Z., Hassan Z. M., Moazzeni S. M. Enhancement of Th1 immune response by CD8&#x3b1;+ dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice. Cellular Immunology. 2009;260(1):28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19712929</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe M., Akbar F., Hasebe A., Horiike N., Onji M. Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. Journal of Gastroenterology. 2003;38(10):962&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">14614603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua H., Liang Z., Li W., et al. Phenotypic and functional maturation of murine dendritic cells (DCs) induced by purified Glycyrrhizin (GL) International Immunopharmacology. 2012;12(3):518&#x2013;525. doi: 10.1016/j.intimp.2012.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2012.01.006</ArticleId><ArticleId IdType="pubmed">22293534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukil A., Biswas A., Das T., Das P. K. 18&#x3b2;-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-&#x3ba;B. The Journal of Immunology. 2005;175(2):1161&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pubmed">16002718</ArticleId></ArticleIdList></Reference><Reference><Citation>Takk P., Firestein G. NF-&#x3ba;B: a key role in inflammatory disease. Journal of Clinical Investigation. 2001;107:7&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC198552</ArticleId><ArticleId IdType="pubmed">11134171</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin A. S., Jr. The NF-&#x3ba;B and I&#x3ba;B proteins: new discoveries and insights. Annual review of immunology. 1996;14(1):649&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">8717528</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarov S. S. NF-&#x3ba;B as a therapeutic target in chronic inflammation: recent advances. Molecular medicine today. 2000;6(11):441&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">11074370</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin A. S. Series introduction: the transcription factor NF-&#x3ba;B and human disease. The Journal of clinical investigation. 2001;107(1):3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC198555</ArticleId><ArticleId IdType="pubmed">11134170</ArticleId></ArticleIdList></Reference><Reference><Citation>May M. J., Ghosh S. Signal transduction through NF-&#x3ba;B. Immunology Today. 1998;19(2):80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">9509763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Karin M. Missing pieces in the NF-&#x3ba;B puzzle. Cell. 2002;109(2):S81&#x2013;S96.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983155</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercurio F., Manning A. M. Multiple signals converging on NF-&#x3ba;B. Current Opinion in Cell Biology. 1999;11(2):226&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">10209157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Song Y., Zhang Z. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice. The American journal of the medical sciences. 2012;344(3):206&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">22197982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherng J.-M., Tsai K.-D., Yu Y.-W., Lin J.-C. Molecular mechanisms underlying chemopreventive activities of glycyrrhizic acid against UVB-radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Radiation Research. 2011;176(2):177&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">21545294</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L., Zhu M.-m., Zhang M.-h., et al. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-&#x3ba;B pathway activation in human umbilical vein endothelial cells. Journal of ethnopharmacology. 2013;148(1):27&#x2013;36. doi: 10.1016/j.jep.2013.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2013.03.035</ArticleId><ArticleId IdType="pubmed">23528363</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Choi K., Jeong E., Kwon D., Benveniste E. N., Choi C. Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia. 2004;47(1):9&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">15139008</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit W. J., Conde J. R., Harrison J. K. Chemokines and Alzheimer&#x2019;s disease. Neurobiology of aging. 2001;22(6):909&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">11754998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajetto A., Bonavia R., Barbero S., Florio T., Schettini G. Chemokines and their receptors in the central nervous system. Frontiers in neuroendocrinology. 2001;22(3):147&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11456467</ArticleId></ArticleIdList></Reference><Reference><Citation>Soufy H., Yassein S., Ahmed A. R., et al. Antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus. African Journal of Traditional, Complementary and Alternative Medicines. 2012;9(3):389&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746675</ArticleId><ArticleId IdType="pubmed">23983372</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong M. D., Simmons C. P., Thanh T. T., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature medicine. 2006;12(10):1203&#x2013;1207. doi: 10.1038/nm1477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1477</ArticleId><ArticleId IdType="pmc">PMC4333202</ArticleId><ArticleId IdType="pubmed">16964257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose P., Griffiths-Johnson D., Collins P., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. The Journal of experimental medicine. 1994;179(3):881&#x2013;887. doi: 10.1084/jem.179.3.881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.3.881</ArticleId><ArticleId IdType="pmc">PMC2191401</ArticleId><ArticleId IdType="pubmed">7509365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitaura M., Nakajima T., Imai T., et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. Journal of Biological Chemistry. 1996;271(13):7725&#x2013;7730. doi: 10.1074/jbc.271.13.7725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.13.7725</ArticleId><ArticleId IdType="pubmed">8631813</ArticleId></ArticleIdList></Reference><Reference><Citation>Teran L. M., Mochizuki M., Bartels J., et al. Th1-and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. American journal of respiratory cell and molecular biology. 1999;20(4):777&#x2013;786. doi: 10.1165/ajrcmb.20.4.3508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.20.4.3508</ArticleId><ArticleId IdType="pubmed">10101011</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamasu M., Nakajima T., Misaki Y., et al. Dermal fibroblasts represent a potent major source of human eotaxin: in vitro production and cytokine-mediated regulation. Cytokine. 1999;11(10):751&#x2013;758. doi: 10.1006/cyto.1999.0487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.1999.0487</ArticleId><ArticleId IdType="pubmed">10525313</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui S., Sonoda Y., Sekiya T., Aizu-Yokota E., Kasahara T. Glycyrrhizin derivative inhibits eotaxin 1 production via STAT6 in human lung fibroblasts. International immunopharmacology. 2006;6(3):369&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">16428072</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukura S., Stellato C., Plitt J. R., et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. The Journal of Immunology. 1999;163(12):6876&#x2013;6883.</Citation><ArticleIdList><ArticleId IdType="pubmed">10586089</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeck J., Woisetschl&#xe4;ger M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-&#x3b1;-induced fibroblasts. The Journal of Immunology. 2001;166(7):4507&#x2013;4515.</Citation><ArticleIdList><ArticleId IdType="pubmed">11254707</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmgaard L. Induction and regulation of IFNs during viral infections. Journal of interferon &amp; cytokine research. 2004;24(8):439&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">15320958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen G. C. Viruses and interferons. Annual Reviews in Microbiology. 2001;55(1):255&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">11544356</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.-F., Wu T.-C., Wu C.-C., et al. Sublingual vaccination with sonicated Salmonella proteins and mucosal adjuvant induces mucosal and systemic immunity and protects mice from lethal enteritis. Apmis. 2011;119(7):468&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">21635554</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunnick J. K., Galasso G. J. Update on clinical trials with exogenous interferon. The Journal of infectious diseases. 1980;142(2):293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">6157757</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. New England Journal of Medicine. 1976;295(10):517&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">950957</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara S., Suzuki M., Suzuki F., Ishida N. The induction of viral inhibitor (s) in mice treated with biological and synthetic immunopotentiators. Microbiology and immunology. 1980;24(1):87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">6767175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y., Takano F. Nitric oxide production in mouse peritoneal macrophages enhanced with glycyrrhizin. Biological and Pharmaceutical Bulletin. 1994;17(5):759&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">7920451</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinada M., Azuma M., Kawai H., et al. Enhancement of interferon-&#x3b3; production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus. Proceedings of the society for experimental biology and medicine. 1986;181(2):205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">3080754</ArticleId></ArticleIdList></Reference><Reference><Citation>Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. The Journal of Immunology. 1979;122(1):175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">310826</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz R. M., Papamatheakis J. D., Chirigos M. A. Interferon: an inducer of macrophage activation by polyanions. Science. 1977;197(4304):674&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">877584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Tang Y., Zhang J., Hu X., Wang Q., Huang J. Therapeutic effects of glycyrrhizic acid on asthma airway inflammation in mice and its mechanism. Zhonghua yi xue za zhi. 2014;94(42):3338&#x2013;3344.</Citation><ArticleIdList><ArticleId IdType="pubmed">25622636</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick F. Cyclooxygenase enzymes: regulation and function. Current pharmaceutical design. 2004;10(6):577&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">14965321</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Feng G., Liu J., et al. Renal cell carcinoma may evade the immune system by converting CD4+ Foxp3-T cells into CD4+ CD25+ Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2. Molecular medicine reports. 2010;3(6):959&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">21472340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Liu J., Cui D., et al. Anti-inflammatory function of Withangulatin A by targeted inhibiting COX-2 expression via MAPK and NF-&#x3ba;B pathways. Journal of cellular biochemistry. 2009;109(3):532&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">19950196</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivier M., Gregory D. J., Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clinical microbiology reviews. 2005;18(2):293&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1082797</ArticleId><ArticleId IdType="pubmed">15831826</ArticleId></ArticleIdList></Reference><Reference><Citation>Trebino C. E., Stock J. L., Gibbons C. P., et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proceedings of the National Academy of Sciences. 2003;100(15):9044&#x2013;9049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC166435</ArticleId><ArticleId IdType="pubmed">12835414</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C. S., Mann M., DuBois R. N. The role of cyclooxygenases+ in inflammation, cancer, and development. Oncogene. 1999;18(55):7908&#x2013;7916.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630643</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz M., Fox B. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. The Journal of Immunology. 1991;146(1):108&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">1845802</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingemann H.-G., Tsoi M.-S., Storb R. Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting. Blood. 1986;68(1):102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">2941083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni Y.-F., Kuai J.-K., Lu Z.-F., et al. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. Journal of Surgical Research. 2011;165(1):e29&#x2013;e35.</Citation><ArticleIdList><ArticleId IdType="pubmed">21074783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang W., O&#x2019;Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">30995504</ArticleId></ArticleIdList></Reference><Reference><Citation>Manetti R., Parronchi P., Giudizi M. G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. The Journal of experimental medicine. 1993;177(4):1199&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190961</ArticleId><ArticleId IdType="pubmed">8096238</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunology today. 1993;14(7):335&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">8103338</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehimi J., Starr S. E., Frank I., et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. The Journal of experimental medicine. 1994;179(4):1361&#x2013;1366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191451</ArticleId><ArticleId IdType="pubmed">7908324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehimi J., Starr S. E., Frank I., et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. The Journal of experimental medicine. 1992;175(3):789&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119140</ArticleId><ArticleId IdType="pubmed">1346797</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994;84(12):4008&#x2013;4027.</Citation><ArticleIdList><ArticleId IdType="pubmed">7994020</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhong J. Y., Gao E. N., Yang H. Effects of glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage. Zhongguo Zhong Yao Za Zhi. 2014;39(19):3841&#x2013;3845.</Citation><ArticleIdList><ArticleId IdType="pubmed">25612451</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael T., Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine. 2003;10(6-7):483&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">13678231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-H., Kato M., Isobe K.-I., Hamaguchi M., Yokochi T., Nakashima I. Dissociated control by glycyrrhizin of proliferation and IL-2 production of murine thymocytes. Cellular immunology. 1995;162(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">7704916</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaruga B., Hong F., Sun R., Radaeva S., Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. The Journal of Immunology. 2003;171(6):3233&#x2013;3244.</Citation><ArticleIdList><ArticleId IdType="pubmed">12960353</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A. M., Horiguchi N., Jeong W. I., Radaeva S., Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcoholism: Clinical and Experimental Research. 2011;35(5):787&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3083482</ArticleId><ArticleId IdType="pubmed">21284667</ArticleId></ArticleIdList></Reference><Reference><Citation>El Kasmi K. C., Smith A. M., Williams L., et al. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. The Journal of Immunology. 2007;179(11):7215&#x2013;7219.</Citation><ArticleIdList><ArticleId IdType="pubmed">18025162</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T., Abe K., Ikeda T., et al. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury. European journal of pharmacology. 2007;576:136&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">17825282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annual review of immunology. 2001;19(1):423&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">11244043</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.-R., Nam D., Yun H.-M., et al. &#x3b2;-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letter. 2011;312(2):178&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.-K., Choi Y. K., Lee H., et al. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways. Molecular pharmacology. 2010;78(1):142&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.&#x2010;h., Hsieh C.&#x2010;. H., Liu W.&#x2010;h., Yin M.&#x2010;c. Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway. Molecular nutrition &amp; food research. 2014;58(7):1426&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">24585461</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojcik M., Zieleniak A., Zurawska-Klis M., Cypryk K., Wozniak L. A. Increased expression of immune-related genes in leukocytes of patients with diagnosed gestational diabetes mellitus (GDM) Experimental Biology and Medicine. 2016;241(5):457&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4950477</ArticleId><ArticleId IdType="pubmed">26568332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanemoto R., Okuyama T., Matsuo H., Okumura T., Ikeya Y., Nishizawa M. The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1&#x3b2;-treated hepatocytes. Biochemistry and biophysics reports. 2015;2:153&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668654</ArticleId><ArticleId IdType="pubmed">29124157</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima A., Yamamoto Y., Yoshinaka N., et al. A new flavanone and other flavonoids from green perilla leaf extract inhibit nitric oxide production in interleukin 1&#x3b2;-treated hepatocytes. Bioscience, biotechnology, and biochemistry. 2015;79(1):138&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">25266050</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuruoka N., Abe K., Wake K., et al. Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice. Inflammation Research. 2009;58(9):593&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">19333727</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Kaibori M., Miki H., et al. Japanese Kampo medicine, ninjinyoeito, inhibits the induction of iNOS gene expression in proinflammatory cytokine-stimulated hepatocytes. British Journal of Pharmaceutical Research. 2014;4:2226&#x2013;2244.</Citation></Reference><Reference><Citation>Colasanti M., Suzuki H. The dual personality of NO. Trends Pharmacology Science. 2000;21(7):249&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">10979862</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui K., Nishizawa M., Ozaki T., et al. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatology. 2007;47(2):686&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">18161049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa M., Ikeya Y., Okumura T., Kimura T. Post-transcriptional inducible gene regulation by natural antisense RNA. Frontiers in Bioscience. 2015;20:1&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25553439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanemaki T., Kitade H., Hiramatsu Y., Kamiyama Y., Okumura T. Stimulation of glycogen degradation by prostaglandin E2 in primary cultured rat hepatocytes. Prostaglandins. 1993;45(5):459&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">8321915</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaruga B., Hong F., Kim W.-H., Gao B. IFN-&#x3b3;/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2004;287(5):G1044&#x2013;G1052.</Citation><ArticleIdList><ArticleId IdType="pubmed">15246962</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T., Kanda T. Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression. International journal of molecular medicine. 1999;4(2):149&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">10402481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.-H., Park S.-W., Kim Y. S., et al. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biological and Pharmaceutical Bulletin. 2007;30(10):1898&#x2013;1904.</Citation><ArticleIdList><ArticleId IdType="pubmed">17917259</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Kaisho T., Akira S. Toll-like receptors. Annual review of immunology. 2015;21(1):335&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12524386</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Yu L., Zhang Y., et al. Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway. International immunopharmacology. 2020;84(106578):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205693</ArticleId><ArticleId IdType="pubmed">32416454</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J. B., H&#xfc;ppner A., Mulrooney-Cousins P. M., Michalak T. I. Differential expression of woodchuck toll-like receptors 1&#x2013;10 in distinct forms of infection and stages of hepatitis in experimental hepatitis B virus infection. Frontiers in microbiology. 2018;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292964</ArticleId><ArticleId IdType="pubmed">30581424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P., Das P. K., Ukil A. Antileishmanial effect of 18&#x3b2;-glycyrrhetinic acid is mediated by toll-like receptor-dependent canonical and noncanonical p38 activation. Antimicrobial agents and chemotherapy. 2015;59(5):2531&#x2013;2539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394830</ArticleId><ArticleId IdType="pubmed">25691644</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L.-N., Li L., Qiu Y.-F., et al. Glycyrrhetinic acid extracted from Glycyrrhiza uralensis Fisch. induces the expression of toll-like receptor 4 in Ana-1 murine macrophages. Journal of Asian natural products research. 2011;13(10):942&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">21972810</ArticleId></ArticleIdList></Reference><Reference><Citation>Graebin C. S. The pharmacological activities of glycyrrhizinic acid (&#x201c;glycyrrhizin&#x201d;) and glycyrrhetinic acid. Reference Series in Phytochemistry. 2018. pp. 245&#x2013;261.</Citation></Reference><Reference><Citation>Liu W., Huang S., Li Y., Zhang K., Zheng X. Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 signaling pathway. Food &amp; nutrition research. 2019;63</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495270</ArticleId><ArticleId IdType="pubmed">31073286</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo El-Magd N. F., El-Karef A., El-Shishtawy M. M., Eissa L. A. Glycyrrhizin and Omega-3 fatty acids have hepatoprotective roles through toll-like receptor-4. Egyptian Journal of Basic and Applied Sciences. 2019;6(1):82&#x2013;98.</Citation></Reference><Reference><Citation>Loiarro M., Ruggiero V., Sette C. Targeting TLR/IL-1R signalling in human diseases. Mediators of inflammation. 2010;2010:12.674363</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852602</ArticleId><ArticleId IdType="pubmed">20396389</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirey K. A., Lai W., Patel M. C., et al. Novel strategies for targeting innate immune responses to influenza. Mucosal immunology. 2016;9(5):1173&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5125448</ArticleId><ArticleId IdType="pubmed">26813341</ArticleId></ArticleIdList></Reference><Reference><Citation>Morale M. G., da Silva Abjaude W., Silva A. M., Villa L. L., Boccardo E. HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis. Scientific reports. 2018;8(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823898</ArticleId><ArticleId IdType="pubmed">29472602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayavara K., Kurosky A., Stafford S. J., et al. Proinflammatory effects of respiratory syncytial virus&#x2013;induced epithelial HMGB1 on human innate immune cell activation. The Journal of Immunology. 2018;201(9):2753&#x2013;2766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6200588</ArticleId><ArticleId IdType="pubmed">30275049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nace G. W., Huang H., Klune J. R., et al. Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology. 2013;58(1):374&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3688695</ArticleId><ArticleId IdType="pubmed">23460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao R., Zhang Y., Kang Y., et al. Glycyrrhizin inhibits PEDV infection and proinflammatory cytokine secretion via the HMGB1/TLR4-MAPK p38 pathway. International journal of molecular sciences. 2020;21(8):p. 2961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215578</ArticleId><ArticleId IdType="pubmed">32340172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica L., De Marchis F., Spitaleri A., et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chemistry &amp; biology. 2007;14(4):431&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">17462578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi M. E., Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Current opinion in genetics &amp; development. 2005;15(5):496&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">10398600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Ward M. F., Fan X.-G., Sama A. E., Li W. Potential role of high mobility group box 1 in viral infectious diseases. Viral immunology. 2006;19(1):3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1782047</ArticleId><ArticleId IdType="pubmed">16553546</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson U., Wang H., Palmblad K., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine. 2000;192(4):565&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193240</ArticleId><ArticleId IdType="pubmed">10952726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Chen D.-z., Li J., et al. Pathogenic role of HMGB1 in SARS? Medical hypotheses. 2004;63(4):691&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127179</ArticleId><ArticleId IdType="pubmed">15325019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiuza C., Bustin M., Talwar S., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood, The Journal of the American Society of Hematology. 2003;101(7):2652&#x2013;2660.</Citation><ArticleIdList><ArticleId IdType="pubmed">12456506</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo R., Sampaolesi M., De Marchis F., et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. The Journal of cell biology. 2004;164(3):441&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172232</ArticleId><ArticleId IdType="pubmed">14744997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohndorf U.-M., Rould M. A., He Q., Pabo C. O., Lippard S. J. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature. 1999;399(6737):708&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">10385126</ArticleId></ArticleIdList></Reference><Reference><Citation>Julkunen I., Sareneva T., Pirhonen J., Ronni T., Mel&#xe9;n K., Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001;12(2-3):171&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">11325600</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisy D., Avilov S. V., Jacob Y., et al. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. Journal of virology. 2012;86(17):9122&#x2013;9133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416134</ArticleId><ArticleId IdType="pubmed">22696656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J., Ng M. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. Journal of General Virology. 2003;84(12):3305&#x2013;3314.</Citation><ArticleIdList><ArticleId IdType="pubmed">14645911</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph T., Cepica A., Brown L., Ikede B. O., Kibenge F. S. Mechanism of cell death during infectious salmon anemia virus infection is cell type-specific. Journal of General Virology. 2004;85(10):3027&#x2013;3036.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo J. F., Mu&#xf1;oz-Fernandez M. A. Severe acute respiratory syndrome, a pathological immune response to the new coronavirus&#x2014;implications for understanding of pathogenesis, therapy, design of vaccines, and epidemiology. Viral immunology. 2004;17(4):535&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">15671750</ArticleId></ArticleIdList></Reference><Reference><Citation>Popper H. Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver. The American journal of pathology. 1975;81(3):p. 609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2032326</ArticleId><ArticleId IdType="pubmed">1108667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>